|
Speciality Spotlight
Critical
Medicine
-
Lena Gamrin, Pia Essen, Eric Hultman, et al (The Department of Anesthesiology and Intensive Care and Clinical Chemistry II, Huddinge University Hospital, Karolinska Institute, Stockholm, Sweden; and the Department of Surgery at State University of New York,Stony Brook, New York)
Protein-Sparing Effect in Skeletal Muscle of Growth Hormone Treatment in Critically III Patients.
Annals of Surgery, April 2000, 231(4), 577-586.
This study investigates the effect of growth hormone (GH) treatment on skeletal muscle protein catabolism in patients with multiple organ failure in the ICU.
20 critically ill ICU patients were randomized into 2 groups – one as control and the other with GH (0.3U/kg/day). Percutaneous muscle biopsy was taken before and 5 days after treatment starting on day 3 to 42 of the patient’s ICU stay. Protein content, protein synthesis, water nucleic acids and free amino acids were analysed.
The fractional protein synthesis rate and muscle free glutaminic increased in the GH group. Total intramuscular water did not increase but the intracellular water increased.
It is concluded that treatment with GH in patients with multiple organ failure, stimulated muscle protein synthesis, increased muscle free glutaminic and increased into a cellular water.